• Sleep Medicine and Psychophysiology
• /
• v.28 no.2
• /
• pp.53-69
• /
• 2021

Sleep disorders, increasingly prevalent in the general population, induce impairment in daytime functioning and other clinical problems. As changes in cortical excitability have been reported as potential pathophysiological mechanisms underlying sleep disorders, multiple studies have explored clinical effects of modulating cortical excitability through non-invasive brain stimulation in treating sleep disorders. In this study, we critically reviewed clinical studies using non-invasive brain stimulation, particularly transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), for treatment of sleep disorders. Previous studies have reported inconsistent therapeutic effects of TMS and tDCS for various kinds of sleep disorders. Specifically, low-frequency repetitive TMS (rTMS) and cathodal tDCS, both of which exert an inhibitory effect on cortical excitability, have shown inconsistent therapeutic effects for insomnia. On the other hand, high-frequency rTMS and anodal tDCS, both of which facilitate cortical excitability, have improved the symptoms of hypersomnia. In studies of restless legs syndrome, high-frequency rTMS and anodal tDCS induced inconsistent therapeutic effects. Single TMS and rTMS have shown differential therapeutic effects for obstructive sleep apnea. These inconsistent findings indicate that the distinctive characteristics of each non-invasive brain stimulation method and specific pathophysiological mechanisms underlying particular sleep disorders should be considered in an integrated manner for treatment of various sleep disorders. Future studies are needed to provide optimized TMS and tDCS protocols for each sleep disorder, considering distinctive effects of non-invasive brain stimulation and pathophysiology of each sleep disorder.

• Physical Therapy Korea
• /
• v.8 no.4
• /
• pp.91-99
• /
• 2001

뇌 손상 후 급성기에 기능의 자발적인 회복이 일어나지만 환자들은 환측의 상지를 잘 사용하지 못하게 된다. 그 결과 원하는 움직임을 억제하는 상황을 발생시키는데 이것을 학습 무사용 증후군(learned nonu se syndrome)이라 한다. 이러한 학습 무사용 증후군을 치료하기 위해 억제-유도 치료(constraint-induced therapy)가 고안되었다. 억제-유도 치료는 연속되는 몇 주간에 걸쳐 매일 많은 시간 동안 건측의 상지를 묶어두고 환측 상지를 사용하게 하여 기능을 반복 학습하게 함으로써 기능을 증진시키는 방법이다. 이미 여러 연구자들이 경두개 자기자극(transcranial magnetic stimulation), 움직임 관련 피질전위(movement-related cortical potential), 기능적 자기공명 영상기법(functional magnetic resonance imaging) 등을 통하여 억제-유도 치료 후 운동피질영역에서의 재조직화를 보고함으로써 기능 증진과 관련된 회복 기전을 뒷받침하고 있다. 억제-유도 치료의 영역은 확대되어 뇌졸중, 척수손상, 고관절 치환술 후로 하지에서의 기능증진을 위하여 연구가 진행되고 있으며 특히 뇌졸중 후 실어증 환자에서 새로운 방법으로 제시되고 있다. 따라서, 억제-유도 치료는 신경학적인 손상 후 움직임의 재활에 있어서 치료-유도를 통한 중추신경계의 회복에 효과적으로 작용할 수 있다.

• Proceedings of the KAIS Fall Conference
• /
• 2011.12a
• /
• pp.244-247
• /
• 2011

Transcranial Magnetic Stimulation(TMS) Navigation System은 자기 자극을 이용한 비 침습적 방법으로 통증 없이 뇌 기능의 활성화 및 재활에 필요한 자극, 자극의 위치, 환자의 모션 등을 3차원 뇌영상에 제공한다. 이 시스템에서 사용되는 소프트웨어는 Talairach 좌표를 적용하여 재구성된 MR 영상을 3차원으로 제공하며, 이를 이용하여 자극의 위치를 표시할 수 있는 기준을 제공한다. 또한 환자의 모션이나 자극 트랜스듀서의 위치를 Talairach 좌표 매핑 소프트웨어 제공하기위해 스테레오 카메라를 이용하여 정확한 좌표를 획득할 수 있는 알고리즘을 적용하였다. 이러한 시스템 개발을 통해 뇌질환 연구와 치료에 다양하게 활용될 수 있을 것으로 기대된다.

• Proceedings of the Korean Institute of Information and Commucation Sciences Conference
• /
• 2009.10a
• /
• pp.325-328
• /
• 2009

In this study, A Magnetic stimulation Pulse Train control technique is introduced and applied to Flyback converter operating in discontinuous conduction mode. In contrast to the conventional pulse width modulation control scheme, the principal idea of a Magnetic stimulation Pulse Train is to achieve output voltage regulation using high and low power pulses. The proposed technique is applicable to any converter operating in discontinuous conduction. However, this work mainly focuses on Flyback topology. In this paper, the main mathematical concept of the new control algorithm is introduced and simulations as well as experimental results are presented.

• 대한핵의학회:학술대회논문집
• /
• 2004.11a
• /
• pp.396.1-396.1
• /
• 2004

• Korean Journal of Biological Psychiatry
• /
• v.24 no.4
• /
• pp.167-174
• /
• 2017

Based on advances in biotechnology and neuroscience, neuromodulation is poised to gain clinical importance as a treatment modality for psychiatric disorders. In addition to old-established electroconvulsive therapy (ECT), clinicians are expected to understand newer forms of neurostimulation, such as deep brain stimulation (DBS), vagus nerve stimulation (VNS), repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS). Given the growing interest in non-invasive neuromodulation technologies, clinicians may seek sufficient information about neuromodulation to inform their clinical practice. A growing literature suggests that applications of non-invasive neuromodulation have evidence particularly for indications where treatments are currently insufficient, such as drug-resistant depression. However, positive neuromodulation studies require replication, and the precise interactions among stimulation, antidepressant medication, and psychotherapy are unknown. Further studies of long-term safety and the impact on the developing brain are needed. Non-invasive neuromodulatory devices could enable more individualized treatment. However, do-it-yourself (DIY) stimulation kits require a better understanding of the effects of more frequent patterns of stimulation and raise concerns about clinical supervision, regulation, and reimbursement. Wide spread enthusiasm for therapeutic potential of neuromodulation in clinical practice settings should be mitigated by the fact that there are still research gaps and challenges associated with non-invasive neuromodulatory devices.

• Proceedings of the KIEE Conference
• /
• 2008.07a
• /
• pp.1991-1992
• /
• 2008

경두개자기자극술(Transcranial Magnetic Sitmulation:이하 TMS)은 두뇌 외부에 설치된 코일을 이용하여 짧은 시간에 강한 펄스 형태의 자기장을 인가하여 두뇌 내부에 유도전기장을 발생시켜 특정 부위의 신경조직을 자극하는 비침습적(noninvasive)인 기술이다. 두뇌 내부에 정확한 자극 분포와 자극 세기를 알기 위해 Zubal Data에 근거한 정밀한 두뇌형상모델을 이용하여 비균질성을 고려해 수치해석을 하였다. 수치해석 결과 복잡한 머리 내부에 유기되는 정확한 유도전기장 분포를 예측하였고 실험을 통해 수치해석의 유효성을 증명하였다.

• Proceedings of the KIEE Conference
• /
• 2007.07a
• /
• pp.1898-1899
• /
• 2007

경두개자기자극술(Transcranial Magnetic Sitmulation:이하 TMS)은 두뇌 외부에 설치된 코일을 이용하여 짧은 시간에 강한 임펄스형태의 자기장을 인가하여 두뇌 내부에 유도전기장을 발생시켜 특정 부위의 신경조직을 자극하는 비침습적(noninvasive)인 기술이다. 두뇌 내부에 정확한 자극 분포와 자극 세기를 알기 위해 Zubal Data에 근거한 정밀한 두뇌형상모델을 이용하여 수치해석 하였다. 수치해석 결과 복잡한 머리 내부에 유기되는 정확한 유도전기장 분포를 예측하였다.

• Korean Journal of Biological Psychiatry
• /
• v.24 no.3
• /
• pp.95-109
• /
• 2017

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neuromodulation technique which can change cortical excitability in targeted area by producing magnetic field pulses with an electromagnetic coil. rTMS treatment has been used to treat various neuropsychiatric disorders including depression. In this review, we evaluate the literature on rTMS for depression by assessing its efficacy on different subtypes of depression and different technical parameters. In particular, we focus on the results of randomized clinical trials and meta-analyses for depression after the US Food and Drug Administration approval in 2008, which acknowledged its efficacy and acceptability. We also review the new forms of rTMS therapy including deep TMS, theta-burst stimulation, and magnetic seizure therapy (MST) that have been under recent investigation. High frequency rTMS over left dorsolateral prefrontal cortex (DLPFC), low frequency rTMS over right DLPFC, or bilateral rTMS is shown to be effective and acceptable in treatment for patients with non-psychotic, unipolar depression either as monotherapy or adjuvant. Deep TMS, theta-burst stimulation and MST are promising new TMS techniques which warrant further research.

• Korean Journal of Biological Psychiatry
• /
• v.16 no.3
• /
• pp.170-180
• /
• 2009

Objectives : To assess clinical improvement and change in plasma brain-derived neurotrophic factor(BDNF) level after repetitive transcranial magnetic stimulation(rTMS) in patients with treatment-resistant schizophrenia. Methods : Seven patients with DSM-IV schizophrenia, who were proven to be treatment-resistant, were treated with 15 sessions of rTMS for three weeks as an adjuvant therapy to antipsychotic treatment. Clinical improvement and change in plasma BDNF level were measured after the treatment period. The symptom severity was assessed with the Positive and Negative Syndrome Scale(PANSS) and the Korean Version of Calgary Depression Scale for Schizophrenia(K-CDSS) at baseline and 7 days after the treatment. Plasma BDNF level was measured by enzyme-linked immunosorbent assay(ELISA) at baseline and 7 days after the treatment. Results : After the rTMS treatment, there was no significant improvement in PANSS total score(Z=-1.693, p=0.090) and no significant change in plasma BDNF was found(Z=-1.183, p=0.237). Negative correlations were found between percentage change in PANSS positive subscale score and duration of illness(rho=-0.991, N=7, p<0.0005, two-tailed), and PANSS negative subscale score at baseline and percentage change in plasma BDNF level(rho=-0.821, N=7, p=0.023, two-tailed). Conclusion : This preliminary study suggests that rTMS didn't make a significant change in clinical symptoms nor in plasma BDNF level in treatment-resistant schizophrenia. Percentage change in plasma BDNF, however, might be correlated with treatment resistance in schizophrenic patients. This is a pilot study with a small sample size, therefore, a further study with a larger sample size is needed.